A Safe, Low-Cost, and Effective Smoking Cessation Treatment



In lung cancer screening volunteers, cytisine may be a secure and efficient smoking cessation treatment, according to a recent study published in the Journal of Thoracic Oncology.

Cytisine, a plant-based alkaloid produced from Cytisus laburnum, has been authorized for use as a smoking cessation aid in Europe since the 1960s. It selectively stimulates nicotinic acetylcholine receptors in a small amount. The two smoking cessation medications that are now FDA-approved in the United States are varenicline and bupropion. In 2018, the Food and Drug Administration granted permission for a research in the US to assess cytisine's efficacy.

Researchers from the Fondazione IRCCS Istituto Nazionale dei Tumori in Milan, Italy, under the direction of Dr. Ugo Pastorino, established the single-center, randomized controlled trial known as the Screening and Multiple Intervention on Lung Epidemics (SMILE) study to examine the efficacy and safety of cytisine as a smoking cessation therapy during low-dose computed tomography (LDCT) screening.

869 current smokers were randomly assigned; 470 (54%) were placed in the intervention arm, which also contained cytisine, and 399 (46%) were placed in the control arm. The main result was a 12-month period of continuous smoking cessation, which was biochemically confirmed using carbon monoxide testing.

The quit rate was 32.1% (151 participants) in the intervention arm and 7.3% (29 participants) in the control arm at the 12-month follow-up. Continual abstinence had an adjusted odds ratio (OR) of 7.2 (95% confidence interval, 4.6 to 11.2). In the intervention arm (399 occurrences among 196 participants), self-reported adverse events occurred more frequently than in the control arm.

According to Dr. Pastorino, "The efficacy and safety found in the SMILE RCT indicate that cytisine, a very inexpensive drug, is a suitable treatment choice for smoking cessation and a workable method to improve LDCT screening outcomes with a potential benefit for all-cause mortality."

By INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER  

Comments

Post a Comment

Popular posts from this blog

Do You Sleep on Your Back or Side? Here's The Research on 'Optimal' Sleep Positions

Image
William Dement, a renowned sleep researcher at Stanford University, is quoted as saying that after 50 years of study, the only reason he can think of for why we sleep is "because we become sleepy." Sleep certainly matters for our health and wellbeing even though it may be, as one researcher put it, "the sole major habit in quest of a function." Do we, however, have it right? What do studies on sleeping positions say? Is there a proper sleeping position? The majority of people favor sleeping on their side. This is encouraging news because people who sleep on their backs are more likely to have trouble falling asleep or breathing during the night. Most of the time, we have a tendency to shift around quite a bit at night. According to a study involving 664 sleepers, on average, participants slept on their side 54% of the time, their back 37% of the time, and their front 7% of the time. Males are more likely to change positions throughout the night and move their arms, ...
Read more

A Briefcase-Sized Box Is Already Making Oxygen on Mars

Image
Currently, the Martian atmosphere is in no way hospitable to Earthlings. It is formed primarily of carbon dioxide and is over 100 times less dense than Earth's atmosphere. It would soon stop breathing completely for any individuals who tried to breathe in it. A modest device, about the size of a suitcase, has been consistently extracting breathable oxygen from the Martian atmosphere on that sandy, arid, alien world. In order to manufacture breathing air for a human expedition to the red planet, it is the first demonstration of the processing of in situ resources for human use on another world. Its name is MOXIE (Mars Oxygen In-Situ Resource Utilization (ISRU) Experiment), and it is a device that utilizes electrolysis to separate Martian carbon dioxide into carbon monoxide and oxygen. It is mounted inside NASA's Perseverance rover. According to the researchers, MOXIE produced oxygen seven times as much between February 2021, when Perseverance arrived, until the end of 2021. Acco...
Read more

New DNA Research Unlocks Secrets of Native Rodents’ Rat Race to New Lands

Image
More than 150 different native rodent species from Australia, New Guinea, and Melanesian islands have had their DNA sequenced in recent studies. It provides a fuller understanding of their connections and the circumstances surrounding their expansion throughout the Pacific. The Australian National University's (ANU) Dr. Emily Roycroft, the study's lead author, said native rodents are an interesting but frequently underappreciated evolutionary group. Dr. Roycroft noted that over 150 species in Australia and New Guinea are unique to those regions and include the rakali, sometimes known as the "water rat," which is frequently spotted swimming in the lakes near Canberra. We now know relatively little about the history and development of native rodents, particularly those found in New Guinea. In order to obtain DNA from museum specimens up to 180 years old, including several extinct and secretive species, the study team developed a novel technique. "One Guadalcanal ra...
Read more